CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Balance at beginning of period at Dec. 31, 2023	$ 1	$ 928,080	$ (106)	$ (770,796)	$ 157,179
Balance at beginning of period (in shares) at Dec. 31, 2023	70,894,889
Increase (Decrease) in Stockholders' Equity
Issuance of common stock in connection with vesting of restricted stock units		(55)			(55)
Issuance of common stock in connection with vesting of restricted stock units (in shares)	353,128
Unrealized gain (loss) on marketable securities			(258)		(258)
Stock-based compensation expense		2,089			2,089
Net loss				(16,941)	(16,941)
Balance at end of period at Mar. 31, 2024	$ 1	930,114	(364)	(787,737)	142,014
Balance at end of period (in shares) at Mar. 31, 2024	71,248,017
Balance at beginning of period at Dec. 31, 2023	$ 1	928,080	(106)	(770,796)	157,179
Balance at beginning of period (in shares) at Dec. 31, 2023	70,894,889
Increase (Decrease) in Stockholders' Equity
Net loss					(27,927)
Balance at end of period at Jun. 30, 2024	$ 1	933,007	(463)	(798,723)	133,822
Balance at end of period (in shares) at Jun. 30, 2024	71,332,825
Balance at beginning of period at Mar. 31, 2024	$ 1	930,114	(364)	(787,737)	142,014
Balance at beginning of period (in shares) at Mar. 31, 2024	71,248,017
Increase (Decrease) in Stockholders' Equity
Issuance of common stock in connection with vesting of restricted stock units		(10)			(10)
Issuance of common stock in connection with vesting of restricted stock units (in shares)	84,808
Unrealized gain (loss) on marketable securities			(99)		(99)
Stock-based compensation expense		2,903			2,903
Net loss				(10,986)	(10,986)
Balance at end of period at Jun. 30, 2024	$ 1	933,007	(463)	(798,723)	133,822
Balance at end of period (in shares) at Jun. 30, 2024	71,332,825
Balance at beginning of period at Dec. 31, 2024	$ 1	1,058,317	97	(902,861)	$ 155,554
Balance at beginning of period (in shares) at Dec. 31, 2024	107,850,124				107,850,124
Increase (Decrease) in Stockholders' Equity
Issuance of common stock in connection with vesting of restricted stock units		(275)			$ (275)
Issuance of common stock in connection with vesting of restricted stock units (in shares)	415,405
Unrealized gain (loss) on marketable securities			337		337
Stock-based compensation expense		3,535			3,535
Net loss				(15,085)	(15,085)
Balance at end of period at Mar. 31, 2025	$ 1	1,061,577	434	(917,946)	144,066
Balance at end of period (in shares) at Mar. 31, 2025	108,265,529
Balance at beginning of period at Dec. 31, 2024	$ 1	1,058,317	97	(902,861)	$ 155,554
Balance at beginning of period (in shares) at Dec. 31, 2024	107,850,124				107,850,124
Increase (Decrease) in Stockholders' Equity
Net loss					$ (30,514)
Balance at end of period at Jun. 30, 2025	$ 1	1,064,631	482	(933,375)	$ 131,739
Balance at end of period (in shares) at Jun. 30, 2025	108,328,794				108,328,794
Balance at beginning of period at Mar. 31, 2025	$ 1	1,061,577	434	(917,946)	$ 144,066
Balance at beginning of period (in shares) at Mar. 31, 2025	108,265,529
Increase (Decrease) in Stockholders' Equity
Issuance of common stock in connection with vesting of restricted stock units		(9)			(9)
Issuance of common stock in connection with vesting of restricted stock units (in shares)	63,265
Unrealized gain (loss) on marketable securities			48		48
Stock-based compensation expense		3,063			3,063
Net loss				(15,429)	(15,429)
Balance at end of period at Jun. 30, 2025	$ 1	$ 1,064,631	$ 482	$ (933,375)	$ 131,739
Balance at end of period (in shares) at Jun. 30, 2025	108,328,794				108,328,794